Yila

قالب شكل علمي · ملخص مرئي · 1:1

LNP mRNA Delivery Graphical Abstract

A square figure whose ring carries one lipid nanoparticle from microfluidic assembly through characterization, intramuscular dosing and endosomal escape to antigen translation and the antibody and T cell response it raises, for vaccine and nucleic acid delivery papers.

آخر تحديث: 16‏/10‏/2026المراجعة: Roxy Liu86.47 ألف21.49 ألف

الموجّه

Create a graphical abstract for a lipid nanoparticle mRNA delivery paper: ionizable lipid/DSPC/cholesterol/PEG-lipid self-assembly around mRNA cargo using microfluidic mixing, LNP characterization (DLS size ~80nm, PDI, encapsulation efficiency), intramuscular injection, cellular uptake via macropinocytosis, endosomal escape mediated by ionizable lipid protonation at low pH, mRNA release into cytoplasm, ribosomal translation of encoded antigen, MHC-I/II presentation, B cell antibody response and CD8+ T cell activation. Circular layout.

ما هذا القالب

The ring reads as one delivery chain for an mRNA vaccine. Ionizable lipid, DSPC, cholesterol and PEG-lipid meet the mRNA strand in a microfluidic mixer and self-assemble; the particle is characterized by DLS size, polydispersity and encapsulation efficiency, injected into muscle, and taken up by recruited antigen-presenting cells through macropinocytosis. Acidification protonates the ionizable lipid, the endosomal membrane destabilizes, and released mRNA is translated by ribosomes into the encoded antigen, which reaches the MHC-I and MHC-II routes and drives both an antibody response and CD8+ T cell activation. A reader should finish able to say where each step happens and what drives it.

العناصر التي يجب تسميتها

  • Lipid inlets

    Ionizable lipid, DSPC, cholesterol and PEG-lipid each enter on their own channel, named at the inlet rather than in a legend.

  • Microfluidic mixer

    Mark the junction where the lipid phase meets the aqueous mRNA stream, with the arrow that leaves it labelled as the assembled particle.

  • Characterization panel

    Put DLS size around 80 nm, polydispersity and encapsulation efficiency beside the cut-open particle, with a leader to the surface PEG chains.

  • Intramuscular injection

    A syringe in the muscle bundle, with the arrow pointing to the antigen-presenting cells recruited to the injection site.

  • Macropinocytosis

    Show the ruffling membrane closing around the particle, label the route, and connect it to the endosome in the next wedge.

  • Endosomal escape

    Show acidification, the protonated ionizable lipid carrying positive charge, the destabilized bilayer and the strand leaving for the cytosol.

  • Ribosomal translation

    Ribosomes moving along the strand, with the product named as the encoded antigen so it is not read as a host protein.

  • Presentation and response

    Split the MHC-I and MHC-II routes, ending one in CD8+ T cell activation and the other in the B cell antibody response.

أين يُستخدم

  • Graphical abstract
  • Paper mechanism figure
  • Grant proposal
  • Defense slides

ما الذي يدقّقه المراجعون

  • Do not draw full escape

    Reviewers look at the endosome wedge first. Most particles stay trapped and are degraded, so keep a visible branch for cargo that never reaches the cytosol rather than showing every particle releasing its load.

  • Numbers match the methods

    The size near 80 nm, the polydispersity and the encapsulation efficiency printed on the figure must match your light-scattering and fluorescence assays; change all three together whenever the lipid molar ratio or flow rate changes.

  • Uptake is not single-route

    Macropinocytosis is one common path for antigen-presenting cells after an intramuscular dose. Add a second branch in the same wedge when your data also show clathrin- or caveolae-dependent entry, so readers do not read one route as the whole story.

  • Keep the two MHC routes apart

    Antigen translated in the cytosol runs mainly through proteasomal degradation onto MHC-I, while MHC-II loading needs secretion and re-uptake or cross-presentation, so the two should never leave the ribosome on a single shared arrow.

كيف تستخدمه في Yila

  1. 1اختر شكلًا
  2. 2صِف موضوع بحثك والخطوات التي تريد إبرازها
  3. 3حسّنه عبر المحادثة، ثم نزّل ملف PNG

نصائح

افعل

  • Give the prompt your own lipid molar ratio, particle size and encapsulation efficiency so the characterization wedge shows real values.
  • Ask for a horizontal strip instead of the ring for a single-column abstract, keeping the same stage headings so the reading order survives.

تجنّب

  • Do not fill every wedge with small type; the ring separates stages by white space, and crowded text hides the order.
  • Do not keep the sample antigen and immune endpoints; swap in the readouts you actually measured before you generate the final version.

أسئلة شائعة

Can this go straight into a paper?

Treat it as a first draft of your graphical abstract. It is an AI-generated raster image, so before submission check every label spelling, every characterization value and the direction of each arrow against your own methods, then keep refining it in chat until it meets the journal's resolution, type size and colour rules.

Can I change elements in the figure?

Not element by element, but you can keep refining it by chatting in Yila: switch the intramuscular dose for an intravenous one, add lymph node drainage, drop an immune endpoint you did not measure, or put your own particle size into the characterization wedge, then generate a new version.

What format is delivered?

You get an AI-generated PNG image in a square format, ready to drop into an abstract, a defense slide or a proposal. It is not a vector graphic, so check how the labels hold up at the size you need before you enlarge the ring across a full printed page.

Is it free?

Reading this page and looking at the sample cost nothing. Generating your own version in Yila consumes credits, and a new account receives 2,500 credits, which is enough to take this delivery chain through several rounds of edits before you settle on a version.

I work on siRNA delivery. Does it still fit?

Yes. Assembly, characterization, uptake and endosomal escape hold for any nucleic acid cargo. Describe the cargo as siRNA, then replace the antigen presentation and immune activation wedges with target knockdown and the phenotypic readout your study actually reports.

Can I get a wide version or other colours?

Say so in the conversation: ask for a landscape frame that suits a wide presentation screen, or for one cool palette across the immune wedges and a warm one for administration, then adjust the result further once you can see how it reads.

تنزيل ملف PNG النموذجي